371 related articles for article (PubMed ID: 26671474)
1. Newborn screening for congenital adrenal hyperplasia in Tokyo, Japan from 1989 to 2013: a retrospective population-based study.
Tsuji A; Konishi K; Hasegawa S; Anazawa A; Onishi T; Ono M; Morio T; Kitagawa T; Kashimada K
BMC Pediatr; 2015 Dec; 15():209. PubMed ID: 26671474
[TBL] [Abstract][Full Text] [Related]
2. Neonatal screening for congenital adrenal hyperplasia in Southern Brazil: a population based study with 108,409 infants.
Kopacek C; de Castro SM; Prado MJ; da Silva CM; Beltrão LA; Spritzer PM
BMC Pediatr; 2017 Jan; 17(1):22. PubMed ID: 28095810
[TBL] [Abstract][Full Text] [Related]
3. Neonatal screening for congenital adrenal hyperplasia in North-Eastern Italy: a report three years into the program.
Cavarzere P; Camilot M; Teofoli F; Tatò L
Horm Res; 2005; 63(4):180-6. PubMed ID: 15818055
[TBL] [Abstract][Full Text] [Related]
4. High reliability of neonatal screening for congenital adrenal hyperplasia in Switzerland.
Steigert M; Schoenle EJ; Biason-Lauber A; Torresani T
J Clin Endocrinol Metab; 2002 Sep; 87(9):4106-10. PubMed ID: 12213856
[TBL] [Abstract][Full Text] [Related]
5. Neonatal Screening for Congenital Adrenal Hyperplasia in Turkey: A Pilot Study with 38,935 Infants.
Güran T; Tezel B; Gürbüz F; Selver Eklioğlu B; Hatipoğlu N; Kara C; Şimşek E; Çizmecioğlu FM; Ozon A; Baş F; Aydın M; Darendeliler F
J Clin Res Pediatr Endocrinol; 2019 Feb; 11(1):13-23. PubMed ID: 30111524
[TBL] [Abstract][Full Text] [Related]
6. Neonatal Screening for Congenital Adrenal Hyperplasia in Turkey: Outcomes of Extended Pilot Study in 241,083 Infants.
Güran T; Tezel B; Çakır M; Akıncı A; Orbak Z; Keskin M; Selver Eklioğlu B; Ozon A; Özbek MN; Karagüzel G; Hatipoğlu N; Gürbüz F; Çizmecioğlu FM; Kara C; Şimşek E; Baş F; Aydın M; Darendeliler F
J Clin Res Pediatr Endocrinol; 2020 Sep; 12(3):287-294. PubMed ID: 32157855
[TBL] [Abstract][Full Text] [Related]
7. A three-year follow-up of congenital adrenal hyperplasia newborn screening.
Pezzuti IL; Barra CB; Mantovani RM; Januário JN; Silva IN
J Pediatr (Rio J); 2014; 90(3):300-7. PubMed ID: 24560529
[TBL] [Abstract][Full Text] [Related]
8. Birth Weight- or Gestational Age-adjusted Second-tier LCMSMS Cutoffs Improve Newborn Screening for CAH in New Zealand.
de Hora MR; Heather NL; Webster D; Albert BB; Hofman PL
J Clin Endocrinol Metab; 2021 Aug; 106(9):e3390-e3399. PubMed ID: 34058748
[TBL] [Abstract][Full Text] [Related]
9. Improved precision of newborn screening for congenital adrenal hyperplasia using weight-adjusted criteria for 17-hydroxyprogesterone levels.
Allen DB; Hoffman GL; Fitzpatrick P; Laessig R; Maby S; Slyper A
J Pediatr; 1997 Jan; 130(1):128-33. PubMed ID: 9003862
[TBL] [Abstract][Full Text] [Related]
10. Impact of Newborn Screening on Clinical Presentation of Congenital Adrenal Hyperplasia.
Navardauskaitė R; Banevičiūtė K; Songailienė J; Grigalionienė K; Čereškevičius D; Šukys M; Mockevicienė G; Smirnova M; Utkus A; Verkauskienė R
Medicina (Kaunas); 2021 Sep; 57(10):. PubMed ID: 34684072
[No Abstract] [Full Text] [Related]
11. Newborn screening for congenital adrenal hyperplasia in Cuba: six years of experience.
González EC; Carvajal F; Frómeta A; Arteaga AL; Castells EM; Espinosa T; Coto R; Pérez PL; Tejeda Y; Del Río L; Segura MT; Almenares P; Robaina R; Fernández JL
Clin Chim Acta; 2013 Jun; 421():73-8. PubMed ID: 23481450
[TBL] [Abstract][Full Text] [Related]
12. Two-year pilot study of newborn screening for congenital adrenal hyperplasia in New South Wales compared with nationwide case surveillance in Australia.
Gleeson HK; Wiley V; Wilcken B; Elliott E; Cowell C; Thonsett M; Byrne G; Ambler G
J Paediatr Child Health; 2008 Oct; 44(10):554-9. PubMed ID: 19012627
[TBL] [Abstract][Full Text] [Related]
13. Screening for congenital adrenal hyperplasia: adjustment of 17-hydroxyprogesterone cut-off values to both age and birth weight markedly improves the predictive value.
Olgemöller B; Roscher AA; Liebl B; Fingerhut R
J Clin Endocrinol Metab; 2003 Dec; 88(12):5790-4. PubMed ID: 14671170
[TBL] [Abstract][Full Text] [Related]
14. Nationwide neonatal screening for congenital adrenal hyperplasia in sweden: a 26-year longitudinal prospective population-based study.
Gidlöf S; Wedell A; Guthenberg C; von Döbeln U; Nordenström A
JAMA Pediatr; 2014 Jun; 168(6):567-74. PubMed ID: 24733564
[TBL] [Abstract][Full Text] [Related]
15. A pilot study on newborn screening for congenital adrenal hyperplasia in Beijing.
Gong LF; Gao X; Yang N; Zhao JQ; Yang HH; Kong YY
J Pediatr Endocrinol Metab; 2019 Mar; 32(3):253-258. PubMed ID: 30817302
[TBL] [Abstract][Full Text] [Related]
16. The influence of seasonality and manufacturer kit lot changes on 17α-hydroxyprogesterone measurements and referral rates of congenital adrenal hyperplasia in newborns.
Pearce M; Dauerer E; DiRienzo AG; Caggana M; Tavakoli NP
Eur J Pediatr; 2017 Jan; 176(1):121-129. PubMed ID: 27900477
[TBL] [Abstract][Full Text] [Related]
17. Neonatal screening for congenital adrenal hyperplasia.
Barra CB; Silva IN; Pezzuti IL; Januário JN
Rev Assoc Med Bras (1992); 2012; 58(4):459-64. PubMed ID: 22930025
[TBL] [Abstract][Full Text] [Related]
18. Congenital adrenal hyperplasia: neonatal mass screening compared with clinical diagnosis only in the Emilia-Romagna region of Italy, 1980-1995.
Balsamo A; Cacciari E; Piazzi S; Cassio A; Bozza D; Pirazzoli P; Zappulla F
Pediatrics; 1996 Sep; 98(3 Pt 1):362-7. PubMed ID: 8784357
[TBL] [Abstract][Full Text] [Related]
19. Neonatal screening for congenital adrenal hyperplasia: 17-hydroxyprogesterone levels and CYP21 genotypes in preterm infants.
Nordenström A; Wedell A; Hagenfeldt L; Marcus C; Larsson A
Pediatrics; 2001 Oct; 108(4):E68. PubMed ID: 11581476
[TBL] [Abstract][Full Text] [Related]
20. Benefits of neonatal screening for congenital adrenal hyperplasia (21-hydroxylase deficiency) in Sweden.
Thil'en A; Nordenström A; Hagenfeldt L; von Döbeln U; Guthenberg C; Larsson A
Pediatrics; 1998 Apr; 101(4):E11. PubMed ID: 9521977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
